Articolul precedent |
Articolul urmator |
387 11 |
Ultima descărcare din IBN: 2024-02-07 08:26 |
SM ISO690:2012 EFREMOV, Andrei, CIUBOTARU, Anatol. Systemic inflammatory response syndrome after extracorporal circulation.. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 284. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 284-284 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. The use of CEC in cardiac surgery causes an acute inflammatory response, which is often unpredictable and presents a significant risk of morbidity and mortality. This is due to the contact of blood through the synthetic circuits. Objective of the study. To study the clinical-evolutionary aspects, laboratory indices and conduct strategies of SIRS post-CEC. Material and Methods. The retrospective study includes a cohort of 400 patients undergoing heart surgery in extracorporeal circulation conditions during the years 2018-2020, which was divided into 2 groups: 107 potential patients to develop SIRS {SIRS criteria}, 293 group of control. Patients underwent a series of biochemical investigations: Lactate, liver enzymes, hemoleukogram, coagulogram. Results. In the high risk group, 86.9% developed SIRS and 13.6% of the low risk group (p <0.05). A lactate greater than 4 mmol / l was presented by all patients who developed SIRS. Elevated liver enzymes (ASAT, ALAT> 41 mmol / l) showed 70.07% of all patients. Leukocytosis greater than 20,000 or a deviation of the leukocyte formula to myelocytes and metamyelocytes presented 85% of patients in the high-risk group, and 11% of the low-risk group. RDW greater than 15% was present in 100% of patients who developed SIRS. Severe forms of SIRS have been associated with severe thrombocytopenia (Pl <50,000) and coagulopathy (IP <60). Conclusion. Fine control of therapeutic interventions results in a low number of patients developing SIRS, improving the general condition. Early postoperative recovery, SIRS prophylaxis results in a drastic decrease in postoperative complications. |
||||||
Cuvinte-cheie cec, SIRS, cec, SIRS |
||||||
|